Quinine Extraction Plant
Quinine Extraction Plant
Mechotech designs and manufactures industrial quinine extraction and purification plants for the production of quinine sulphate (C₄₀H₄₈N₄O₄·H₂SO₄) at 98–99.5% purity from Cinchona officinalis, C. calisaya, and C. pubescens bark — the primary natural source of antimalarial quinine alkaloids. Quinine remains a first-line treatment for severe and chloroquine-resistant malaria under WHO protocols, and is listed on the WHO Model List of Essential Medicines. Mechotech's acid-base alkaloid isolation plants are designed to pharmaceutical manufacturing standards and compliant with Indian Schedule M, WHO-GMP, and BP/IP pharmacopoeial specifications.
Cinchona bark contains a complex mixture of alkaloids including quinine (2–7%), quinidine (a stereoisomer), cinchonine, cinchonidine, and over 25 minor alkaloids. Mechotech's quinine extraction process uses a validated acid-base isolation route: alkaloids are extracted into acidic aqueous solution as salts, clarified, basified to precipitate free-base alkaloids, extracted into organic solvent, and quinine is selectively crystallised as its sulphate salt using the differential solubility of quinine bisulphate. The process is carefully controlled to separate quinine from quinidine (its valuable but pharmacologically distinct diastereomer) which is recovered separately. All plants include multi-solvent recovery systems and full pharmaceutical batch documentation capability.
Manufacturing Process
Plant Material Preparation
Dried Cinchona bark (preferably C. calisaya or C. pubescens for high quinine content) is coarsely milled to 1–3 mm particle size to balance extraction surface area with filtration ease. Incoming bark is tested for total alkaloid content (typically 6–12% total alkaloids) and quinine:quinidine ratio by HPLC (C. calisaya bark is typically 3:1 to 5:1 quinine:quinidine ratio, making it the preferred source for quinine-specific extraction). Moisture is adjusted to below 10%.
Acid Extraction
Milled Cinchona bark is mixed with 0.5–1.5% aqueous sulphuric acid at 60–70°C for 3–4 hours with agitation in a SS 316L lined extraction vessel. Acid converts all bark alkaloids (quinine, quinidine, cinchonine, cinchonidine) to their water-soluble bisulphate or sulphate salts. Three sequential extraction stages are used with fresh acid each time to achieve greater than 90% alkaloid extraction efficiency. The combined acidic extracts are filtered through a plate-and-frame press and cartridge filters.
Basification & Free-Base Precipitation
Clarified acidic alkaloid solution is transferred to a large-volume basification vessel with overhead agitation. Sodium hydroxide (20–25% solution) is metered in with vigorous mixing to raise pH to 9.5–10.5. At this pH, all cinchona free-base alkaloids precipitate as a fluffy pale yellow-cream coloured solid. The temperature is maintained at 40–50°C during basification for better precipitation. The basified slurry is filtered through a centrifuge or pressure filter to collect total free-base alkaloids.
Organic Solvent Extraction & Quinine Enrichment
Total free-base alkaloid cake is dissolved in dichloromethane or toluene-chloroform mixture at 40°C (organic phase:alkaloid 10:1 to 15:1 v/w). The organic solution is washed with dilute sodium hydroxide to remove acidic impurities and coloured tannin derivatives. The organic phase is then treated with dilute sulphuric acid in a controlled addition — quinine bisulphate, having lower solubility than quinidine bisulphate, preferentially crystallises at a specific H₂SO₄ concentration, allowing selective precipitation of crude quinine bisulphate while quinidine remains dissolved.
Crystallisation / Quinine Sulphate Production
Crude quinine bisulphate is converted to the dihydrate sulphate form by redissolving in dilute H₂SO₄ (0.5%) at 50°C, adjusting pH to 6.5–7.0, and cooling slowly to 10°C with controlled agitation. Quinine sulphate dihydrate crystallises as white to off-white fine needles. The crystals are collected by centrifugation, washed with cold purified water, and subjected to recrystallisation from hot acidified water (pH 6.5) to achieve 98–99.5% purity. Mother liquors are retained for quinidine sulphate recovery.
Drying & QC Testing
Quinine sulphate crystals are dried in a vacuum tray dryer at 40–50°C (low temperature to preserve the dihydrate form; excessive heat causes loss of water of crystallisation). Finished product is tested by HPLC (quinine assay target 98–99.5%, quinidine below 0.5%, cinchonine and cinchonidine below specified limits), specific optical rotation ([α]D²⁰ = −237° to −245° for quinine sulphate in 0.1 N H₂SO₄), residual solvents, heavy metals, and microbial quality. Batch CoA is generated and product filled into sealed HDPE drums under nitrogen.
Applications
- Pharmaceutical API manufacture — quinine sulphate is an essential medicine for treatment of severe malaria (Plasmodium falciparum) resistant to chloroquine, administered by IV infusion or oral tablets per WHO treatment protocol
- Antimalarial tablet and injectable manufacturing — quinine sulphate and quinine dihydrochloride incorporated in 300 mg and 600 mg tablets and injectable formulations by pharmaceutical companies in India, Africa, and Southeast Asia
- Tonic water and bitter beverages — food-grade quinine (maximum 83 mg/l in EU; 83 ppm in US FDA) used as a bittering agent in tonic water, bitter lemon, and other carbonated drinks
- Quinidine sulphate production — the quinidine-rich mother liquors from quinine crystallisation provide a starting material for quinidine sulphate isolation, a class Ia antiarrhythmic drug
- Antimalarial research and QC standards — high-purity quinine used as reference standards, HPLC calibration standards, and pharmacological research tools in academic and commercial research
- Lupus and arthritis treatment — quinoline alkaloids used in hydroxychloroquine (synthetic analogue) production and quinine itself has anti-inflammatory applications
- Veterinary medicine — quinine formulations used in treatment of babesiosis and other protozoal infections in horses and ruminants
Key Features
Selective Quinine Bisulphate Crystallisation
The critical differentiating step in quinine extraction is the selective precipitation of quinine bisulphate from the mixed-alkaloid organic solution using controlled sulphuric acid addition. Mechotech's process design uses precise acid concentration and temperature control at this stage to exploit the 3-fold difference in solubility between quinine bisulphate and quinidine bisulphate, achieving quinine-selective crystallisation with minimal quinidine co-precipitation, starting at crude purity of 80–90% quinine before recrystallisation.
Quinidine By-Product Recovery
Quinidine sulphate (a cardiac antiarrhythmic API valued at USD 80–150/kg) is recovered from the mother liquors after quinine crystallisation using a separate crystallisation circuit included in Mechotech's plant package. This by-product recovery converts what would otherwise be a waste stream into a high-value pharmaceutical ingredient, significantly improving the overall economics of the Cinchona extraction operation.
Pharmaceutical-Grade GMP Construction
All product-contact equipment is fabricated in SS 316L or acid-resistant lined (HDPE or glass-lined) reactors for acid steps, with electro-polished surfaces, validated CIP systems, calibrated instrumentation with 21 CFR Part 11-compatible data logging, and full batch documentation capability supporting WHO-GMP, USFDA, and EU GMP inspection readiness for pharmaceutical API manufacture.
Multi-Solvent Recovery System
The plant handles dichloromethane (or toluene) used in the organic extraction stage with a dedicated solvent recovery distillation column achieving >95% DCM recovery. Recovered DCM is tested for purity and water content before reuse. Separate recovery of the organic and aqueous phases prevents cross-contamination and maintains solvent specification across batches.
Low-Temperature Drying for Hydrate Preservation
Quinine sulphate is a dihydrate (contains two molecules of water of crystallisation essential to its pharmacopoeial identity). Mechotech specifies low-temperature vacuum tray drying at 40–50°C, below the dehydration temperature, with in-process Karl Fischer water content monitoring to ensure the finished product retains its dihydrate form and passes the water content specification of the BP and IP monographs (4.5–5.5% water).
Frequently Asked Questions
What is the quinine content of Cinchona bark and what total production yield can I expect?
How does Mechotech's process separate quinine from quinidine, which have very similar structures?
What regulatory approvals are required to manufacture quinine sulphate API in India?
Can the Cinchona alkaloid plant also produce chloroquine or hydroxychloroquine?
Ready to discuss your project?
Get a free quote and technical consultation from our engineering team.